3-Benzyl-3-aza-bicyclo[3.2.1]octane-8-carbonitrile
95%
- Product Code: 65617
CAS:
141380-31-6
| Molecular Weight: | 226.32 g./mol | Molecular Formula: | C₁₅H₁₈N₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28404913 | |
| Melting Point: | Boiling Point: | 364.2±35.0 °C(Predicted) | |
| Density: | 1.11±0.1 g/cm3(Predicted) | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its unique bicyclic structure makes it a valuable scaffold for designing drugs that target the central nervous system, particularly in the development of treatments for neurological disorders such as Parkinson's disease and schizophrenia. Additionally, it is explored for its potential in creating compounds with anti-inflammatory and analgesic properties, contributing to the development of new pain management therapies. Researchers also investigate its role in modulating neurotransmitter systems, which could lead to advancements in psychiatric medications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿14,850.00 |
+
-
|
| 0.250 | 10-20 days | ฿25,650.00 |
+
-
|
| 1.000 | 10-20 days | ฿51,300.00 |
+
-
|
3-Benzyl-3-aza-bicyclo[3.2.1]octane-8-carbonitrile
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its unique bicyclic structure makes it a valuable scaffold for designing drugs that target the central nervous system, particularly in the development of treatments for neurological disorders such as Parkinson's disease and schizophrenia. Additionally, it is explored for its potential in creating compounds with anti-inflammatory and analgesic properties, contributing to the development of new pain management therapies. Researchers also investigate its role in modulating neurotransmitter systems, which could lead to advancements in psychiatric medications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :